KR101333851B1 - 유기 화합물 - Google Patents

유기 화합물 Download PDF

Info

Publication number
KR101333851B1
KR101333851B1 KR1020077010191A KR20077010191A KR101333851B1 KR 101333851 B1 KR101333851 B1 KR 101333851B1 KR 1020077010191 A KR1020077010191 A KR 1020077010191A KR 20077010191 A KR20077010191 A KR 20077010191A KR 101333851 B1 KR101333851 B1 KR 101333851B1
Authority
KR
South Korea
Prior art keywords
staurosporin
benzoyl
delete delete
ethanol
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
KR1020077010191A
Other languages
English (en)
Korean (ko)
Other versions
KR20070083979A (ko
Inventor
파스칼 왼
베른트 코흐
미하엘 무츠
Original Assignee
노파르티스 아게
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35501294&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR101333851(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 노파르티스 아게 filed Critical 노파르티스 아게
Publication of KR20070083979A publication Critical patent/KR20070083979A/ko
Application granted granted Critical
Publication of KR101333851B1 publication Critical patent/KR101333851B1/ko
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Extraction Or Liquid Replacement (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
KR1020077010191A 2004-11-05 2005-11-03 유기 화합물 Expired - Lifetime KR101333851B1 (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US62534304P 2004-11-05 2004-11-05
US60/625,343 2004-11-05
US64213105P 2005-01-07 2005-01-07
US60/642,131 2005-01-07
PCT/EP2005/011789 WO2006048296A1 (en) 2004-11-05 2005-11-03 Organic compounds

Related Child Applications (2)

Application Number Title Priority Date Filing Date
KR1020127022584A Division KR101289998B1 (ko) 2004-11-05 2005-11-03 유기 화합물
KR1020127022582A Division KR101265850B1 (ko) 2004-11-05 2005-11-03 유기 화합물

Publications (2)

Publication Number Publication Date
KR20070083979A KR20070083979A (ko) 2007-08-24
KR101333851B1 true KR101333851B1 (ko) 2013-11-27

Family

ID=35501294

Family Applications (3)

Application Number Title Priority Date Filing Date
KR1020127022584A Expired - Lifetime KR101289998B1 (ko) 2004-11-05 2005-11-03 유기 화합물
KR1020077010191A Expired - Lifetime KR101333851B1 (ko) 2004-11-05 2005-11-03 유기 화합물
KR1020127022582A Expired - Lifetime KR101265850B1 (ko) 2004-11-05 2005-11-03 유기 화합물

Family Applications Before (1)

Application Number Title Priority Date Filing Date
KR1020127022584A Expired - Lifetime KR101289998B1 (ko) 2004-11-05 2005-11-03 유기 화합물

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020127022582A Expired - Lifetime KR101265850B1 (ko) 2004-11-05 2005-11-03 유기 화합물

Country Status (31)

Country Link
US (2) US8198435B2 (enExample)
EP (3) EP2955186A1 (enExample)
JP (4) JP5057986B2 (enExample)
KR (3) KR101289998B1 (enExample)
CN (2) CN102993213A (enExample)
AR (1) AR052322A1 (enExample)
AU (2) AU2005300693B2 (enExample)
BR (1) BRPI0517689A (enExample)
CA (1) CA2584911C (enExample)
CY (1) CY1113059T1 (enExample)
DK (1) DK1812448T3 (enExample)
EC (1) ECSP12007431A (enExample)
ES (1) ES2388142T3 (enExample)
GT (1) GT200500311A (enExample)
HK (1) HK1211587A1 (enExample)
HR (1) HRP20120652T1 (enExample)
IL (3) IL182691A (enExample)
JO (1) JO2897B1 (enExample)
MA (1) MA29033B1 (enExample)
MX (2) MX2007005429A (enExample)
MY (2) MY147404A (enExample)
NO (2) NO338960B1 (enExample)
NZ (3) NZ554653A (enExample)
PE (3) PE20130377A1 (enExample)
PL (1) PL1812448T3 (enExample)
PT (1) PT1812448E (enExample)
RU (2) RU2394038C2 (enExample)
SI (1) SI1812448T1 (enExample)
TN (1) TNSN07165A1 (enExample)
TW (4) TWI455941B (enExample)
WO (1) WO2006048296A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2054040E (pt) * 2006-08-16 2011-06-30 Novartis Ag Método para produzir dispersões sólidas de compostos terapêuticos altamente cristalinos
EP2327706A1 (en) 2009-11-30 2011-06-01 Novartis AG Polymorphous forms III and IV of N-benzoyl-staurosporine
KR20160008267A (ko) 2014-07-14 2016-01-22 주식회사 윈스 네트워크 기반 영상감시체계에서의 사용자 행위 분석 시스템
US20200010481A1 (en) 2017-03-06 2020-01-09 Teva Pharmaceutical Works Ltd. Solid state forms of midostaurin
WO2019215759A1 (en) * 2018-05-09 2019-11-14 Alaparthi Lakshmi Prasad An improved process for preparation of midostaurin
IT201900004729A1 (it) 2019-03-29 2020-09-29 Procos Spa Processo per la preparazione di midostaurina ad elevato grado di purezza
WO2020261293A1 (en) * 2019-06-24 2020-12-30 Dr. Reddy's Laboratories Limited Process for preparation of midostaurin
IT201900014346A1 (it) 2019-08-08 2021-02-08 Procos Spa Processo per la preparazione di midostaurina amorfa con un basso contenuto di solvente organico residuo
IT202000004291A1 (it) 2020-03-02 2021-09-02 Indena Spa Processo per la purificazione di alcaloidi indolo carbazolici
CN111393454A (zh) * 2020-05-07 2020-07-10 奥锐特药业(天津)有限公司 米哚妥林的新晶型及其制备方法
CN115124551B (zh) * 2021-03-24 2024-04-30 奥锐特药业(天津)有限公司 一种高纯度米哚妥林的制备方法
WO2023205504A1 (en) * 2022-04-22 2023-10-26 Rutgers, The State University Of New Jersey Formulations and methods for treating epidermolysis bullosa simplex and related conditions

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05247055A (ja) * 1992-03-03 1993-09-24 Meiji Seika Kaisha Ltd スタウロスポリン誘導体及びそれを含有する抗腫瘍効果増強剤

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5373501A (en) * 1976-12-11 1978-06-30 Kitasato Inst Novel antibiotics amm2282 and process for preparing same
JPS60185719A (ja) 1984-03-06 1985-09-21 Ajinomoto Co Inc 抗腫瘍剤
IL86632A0 (en) * 1987-06-15 1988-11-30 Ciba Geigy Ag Derivatives substituted at methyl-amino nitrogen
US5093330A (en) 1987-06-15 1992-03-03 Ciba-Geigy Corporation Staurosporine derivatives substituted at methylamino nitrogen
US5073633A (en) 1989-03-23 1991-12-17 Bristol-Myers Company BMY-41950 antitumor antibiotic
US5096330A (en) * 1990-06-21 1992-03-17 M-B-W Inc. Pitch control mechanism for a surface finishing machine
JPH05247955A (ja) 1992-03-06 1993-09-24 Taisei Corp 擁壁の施工方法
EP0575955B1 (en) 1992-06-22 1999-09-15 Kyowa Hakko Kogyo Co., Ltd. Process for producing staurosporine derivatives
AU2565895A (en) * 1994-06-01 1995-12-21 Ciba-Geigy Ag Indolocarbazole derivatives for sensitizing multidrug-resistant cells to antitumor agents
JP4070810B2 (ja) * 1995-12-11 2008-04-02 セファロン・インコーポレイテッド タンパク質キナーゼｃの阻害剤としての縮合イソインドロン
EP1214336A1 (en) * 1999-08-30 2002-06-19 Universität Zürich Synthesis of template-fixed beta-hairpin loop mimetics
BR0208306A (pt) 2001-03-26 2004-03-09 Novartis Ag Composições farmacêuticas
KR100407758B1 (ko) * 2001-08-27 2003-12-01 씨제이 주식회사 스타틴의 제조에 있어서 락톤화 방법
WO2004094645A1 (en) * 2003-04-22 2004-11-04 Lonza Ag Process for the recovery of staurosporine from a fermentation broth

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05247055A (ja) * 1992-03-03 1993-09-24 Meiji Seika Kaisha Ltd スタウロスポリン誘導体及びそれを含有する抗腫瘍効果増強剤

Also Published As

Publication number Publication date
JP5057986B2 (ja) 2012-10-24
JP2015063569A (ja) 2015-04-09
RU2007120695A (ru) 2008-12-10
KR101265850B1 (ko) 2013-05-20
CA2584911C (en) 2017-10-24
EP2272850A2 (en) 2011-01-12
US8710216B2 (en) 2014-04-29
TWI530501B (zh) 2016-04-21
MA29033B1 (fr) 2007-11-01
BRPI0517689A (pt) 2008-10-14
PT1812448E (pt) 2012-08-24
TW201247681A (en) 2012-12-01
CY1113059T1 (el) 2016-04-13
NZ599033A (en) 2012-09-28
JP2017061578A (ja) 2017-03-30
AU2005300693B2 (en) 2010-08-19
EP2955186A1 (en) 2015-12-16
TW201446773A (zh) 2014-12-16
DK1812448T3 (da) 2012-08-27
TNSN07165A1 (en) 2008-11-21
US8198435B2 (en) 2012-06-12
NO340404B1 (no) 2017-04-18
PL1812448T3 (pl) 2012-10-31
EP1812448B1 (en) 2012-05-23
WO2006048296A1 (en) 2006-05-11
US20120322789A1 (en) 2012-12-20
TW200628474A (en) 2006-08-16
HK1211587A1 (en) 2016-05-27
MY147404A (en) 2012-11-30
EP2272850B1 (en) 2017-05-10
EP1812448A1 (en) 2007-08-01
TWI433852B (zh) 2014-04-11
NO20161152A1 (no) 2007-05-30
EP2272850A3 (en) 2011-09-21
IL182691A0 (en) 2007-09-20
AU2009245817A1 (en) 2009-12-24
MX2007005429A (es) 2007-05-18
AR052322A1 (es) 2007-03-14
CN102627658A (zh) 2012-08-08
ECSP12007431A (es) 2012-06-29
AU2005300693A1 (en) 2006-05-11
TWI530500B (zh) 2016-04-21
RU2467012C2 (ru) 2012-11-20
JP2012149099A (ja) 2012-08-09
IL207702A0 (en) 2010-12-30
CA2584911A1 (en) 2006-05-11
TW201247680A (en) 2012-12-01
JP5701246B2 (ja) 2015-04-15
KR20070083979A (ko) 2007-08-24
RU2009137788A (ru) 2011-04-20
MX346525B (es) 2017-03-23
NO338960B1 (no) 2016-11-07
KR20120101600A (ko) 2012-09-13
AU2009245817B2 (en) 2013-02-21
IL217571A (en) 2017-07-31
NO20072290L (no) 2007-05-30
KR20120101601A (ko) 2012-09-13
KR101289998B1 (ko) 2013-07-30
PE20130377A1 (es) 2013-04-03
IL182691A (en) 2013-02-28
ES2388142T3 (es) 2012-10-09
HK1108881A1 (en) 2008-05-23
RU2394038C2 (ru) 2010-07-10
JO2897B1 (en) 2015-09-15
JP2008518995A (ja) 2008-06-05
HRP20120652T1 (hr) 2012-09-30
TWI455941B (zh) 2014-10-11
NZ588025A (en) 2012-04-27
CN102993213A (zh) 2013-03-27
NZ554653A (en) 2010-10-29
PE20090433A1 (es) 2009-05-05
PE20060947A1 (es) 2006-10-30
US20090137552A1 (en) 2009-05-28
MY154878A (en) 2015-08-14
IL207702A (en) 2016-09-29
SI1812448T1 (sl) 2012-09-28
GT200500311A (es) 2006-05-22

Similar Documents

Publication Publication Date Title
JP5701246B2 (ja) 有機化合物
EP2710015B1 (en) Polymorph of rifaximin and process for the preparation thereof
HK1149754A (en) Process for purifying staurosporine
HK1108881B (en) Organic compounds
CN101048416A (zh) 有机化合物
KR20080095859A (ko) 고체 형태의 피롤로피리미딘 유도체 및 항종양제로서의그의 용도

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20070504

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
AMND Amendment
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20101101

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20120629

Patent event code: PE09021S01D

A107 Divisional application of patent
AMND Amendment
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20120829

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20130117

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20120629

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

J201 Request for trial against refusal decision
PJ0201 Trial against decision of rejection

Patent event date: 20130215

Comment text: Request for Trial against Decision on Refusal

Patent event code: PJ02012R01D

Patent event date: 20130117

Comment text: Decision to Refuse Application

Patent event code: PJ02011S01I

Appeal kind category: Appeal against decision to decline refusal

Decision date: 20131106

Appeal identifier: 2013101001096

Request date: 20130215

AMND Amendment
PB0901 Examination by re-examination before a trial

Comment text: Amendment to Specification, etc.

Patent event date: 20130315

Patent event code: PB09011R02I

Comment text: Request for Trial against Decision on Refusal

Patent event date: 20130215

Patent event code: PB09011R01I

Comment text: Amendment to Specification, etc.

Patent event date: 20120829

Patent event code: PB09011R02I

Comment text: Amendment to Specification, etc.

Patent event date: 20101101

Patent event code: PB09011R02I

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20130424

Patent event code: PE09021S01D

B701 Decision to grant
PB0701 Decision of registration after re-examination before a trial

Patent event date: 20131106

Comment text: Decision to Grant Registration

Patent event code: PB07012S01D

Patent event date: 20130325

Comment text: Transfer of Trial File for Re-examination before a Trial

Patent event code: PB07011S01I

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20131121

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20131121

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
FPAY Annual fee payment

Payment date: 20161028

Year of fee payment: 4

PR1001 Payment of annual fee

Payment date: 20161028

Start annual number: 4

End annual number: 4

FPAY Annual fee payment

Payment date: 20171027

Year of fee payment: 5

PR1001 Payment of annual fee

Payment date: 20171027

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 20201028

Start annual number: 8

End annual number: 8

PR1001 Payment of annual fee

Payment date: 20211027

Start annual number: 9

End annual number: 9

PR1001 Payment of annual fee

Payment date: 20221027

Start annual number: 10

End annual number: 10

PR1001 Payment of annual fee

Payment date: 20241029

Start annual number: 12

End annual number: 12